56 th EASD Annual Meeting of the European Association for the Study of Diabetes
- PDF / 52,145,522 Bytes
- 485 Pages / 595.276 x 790.866 pts Page_size
- 92 Downloads / 179 Views
ABSTRACTS
56th EASD Annual Meeting of the European Association for the Study of Diabetes 21–25 September 2020 Abstracts
OP 47 Thinking about diabetes complications in the brain OP 48 Insulin secretion in various subgroups
Index of Oral Presentations Index of Poster Sessions OP 01 Diabetes complications: new insights from cutting edge epidemiology OP 02 News on the insulin secretion front OP 03 Insulin sensitivity and biomarkers OP 04 Central actions in diabetes OP 05 Glucose-lowering therapies and the liver OP 06 Uncomplicating the pathogenesis of diabetes complications in humans OP 07 Smoke on the water: Is BAT still hot? OP 08 Charting human beta cell failure in type 1 diabetes OP 09 Novel agents in type 1 diabetes OP 10 Developing better insulins OP 11 From diagnostics to the end-stage of diabetic kidney disease OP 12 NAFLD: Is it all about the liver? OP 13 Diabetic retinopathy: see what's new? OP 14 Taking the long view of diabetes OP 15 Pregnancy in diabetes prediction and outcomes OP 16 Signals and networks in beta cell failure OP 17 Broken heart in diabetes OP 18 Unlocking the potential of digital health OP 19 Decoding the heritable basis of type 2 diabetes OP 20 Feeding the pipeline: from drugs to surgery OP 21 SGLT-2 inhibitors: at the heart of the matter OP 22 New Treatments for NAFLD: Hope or Hype? OP 23 Addressing potential new treatments of diabetic kidney disease OP 24 Glucagon and hormones beyond OP 25 Incretin based therapies OP 26 Unusual forms of diabetes OP 27 Macrovascular complications and beyond OP 28 Linking inflammation to metabolism OP 29 What's new in automated insulin delivery OP 30 Understanding the mechanisms of diabetic kidney disease OP 31 Novel aspects of diabetic neuropathy OP 32 Reducing the burden of hypoglycaemia OP 33 What exercise does OP 34 Back to the future: risk markers in diabetes OP 35 Diet: not only quantity matters OP 36 On the road to human islet failure in type 2 diabetes OP 37 A deep dive into the mechanisms of diabetes OP 38 Triggers and drivers of beta cell failure in type 1 diabetes OP 39 Gastro-entero pancreatic factors: organoids, mice and men OP 40 New aspects of novel therapies OP 41 Fatty matters OP 42 Diabetes care is expensive OP 43 Developing beta cells OP 44 Modelling metabolism: lessons from animals OP 45 Diabetic foot: new developments in wound healing OP 46 Challenges in delivering diabetes care: new solutions
PS 01 Diabetes and early death PS 02 Living with chronic diabetes complications PS 03 Micro- and macrovascular complications of diabetes PS 04 Global view on diabetes complications PS 05 Type 2 diabetes treatment IRL PS 06 Unusual forms of diabetes PS 07 Molecular insights into glucose abnormalities PS 08 Pathophysiology of glucose homeostasis PS 09 The inner workings of the pancreas PS 10 Islets and antibodies in type 1 diabetes PS 11 Markers and phenotypes of glucose traits PS 12 Global aspects on the epidemiology of type 2 diabetes PS 13 Risk factors for type 2 diabetes PS 14 Prevalence of type 2 diabetes around the world PS 15 Risk factors
